- $1.48bn
- $2.27bn
- $1.37bn
Brief: Conmed Corporation Announces Third Quarter 2022 Financial Results
U.S. RESEARCH ROUNDUP- Boeing, Cooper Companies, Northern Trust
NYSE ORDER IMBALANCE 54427.0 SHARES ON SELL SIDE
Brief: Conmed Agrees To Acquire Biorez For Cash Consideration Of $85 Mln
U.S. RESEARCH ROUNDUP-Boston Properties, Equinix, Peoples Financial Services
Brief: Conmed Corporation Announces Second Quarter 2022 Financial Results
NYSE ORDER IMBALANCE 102771.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 100000.0 SHARES ON BUY SIDE
Brief: Conmed Corporation Announces Pricing Of Upsized $700 Million Offering Of Convertible Senior Notes
Conmed drops on $600 mln convertible debt offering
Brief: Conmed Corporation Announces Private Offering Of $600 Mln Of Convertible Senior Notes
Brief: Conmed Announces Definitive Agreement To Acquire In2bones Global, Inc.
Brief: Conmed Corporation Announces First Quarter 2022 Financial Results
NYSE ORDER IMBALANCE 63146.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Cross Country Healthcare, First Solar, ServiceNow
Conmed Corp reports results for the quarter ended in December - Earnings Summary
Diagnostics, Williams-Sonoma, Cytokinetics
U.S. STOCKS ON THE MOVE-Vaccine makers, SeaChange, Voya Financial, BiondVax
U.S. STOCKS ON THE MOVE-Reliance Global, Allakos, Acasti Pharma, CalAmp Corp